Phreesia (NYSE:PHR) Lowered to Hold Rating by Wells Fargo & Company

Wells Fargo & Company lowered shares of Phreesia (NYSE:PHR) from a strong-buy rating to a hold rating in a report published on Wednesday morning,Zacks.com reports.

A number of other research analysts have also recently weighed in on the company. DA Davidson dropped their price target on Phreesia from $35.00 to $30.00 and set a “buy” rating for the company in a research report on Friday, January 23rd. KeyCorp dropped their price target on Phreesia from $15.00 to $12.00 and set an “overweight” rating for the company in a research report on Monday, April 13th. Mizuho dropped their price target on Phreesia from $22.00 to $19.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. Weiss Ratings restated a “sell (e+)” rating on shares of Phreesia in a research report on Wednesday, January 28th. Finally, Needham & Company LLC dropped their price objective on Phreesia from $35.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, March 31st. Ten research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Phreesia presently has an average rating of “Hold” and an average price target of $19.06.

Phreesia Trading Down 3.7%

Shares of PHR stock opened at $8.84 on Wednesday. Phreesia has a fifty-two week low of $7.77 and a fifty-two week high of $32.76. The stock has a market cap of $545.74 million, a P/E ratio of 294.50 and a beta of 0.89. The business has a fifty day simple moving average of $9.76 and a 200-day simple moving average of $14.17. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, March 30th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The firm had revenue of $127.07 million during the quarter, compared to analysts’ expectations of $126.75 million. During the same quarter in the prior year, the business earned ($0.11) EPS. The company’s quarterly revenue was up 15.9% compared to the same quarter last year. On average, analysts forecast that Phreesia will post 0.28 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider David Linetsky sold 8,332 shares of Phreesia stock in a transaction dated Friday, April 10th. The stock was sold at an average price of $8.07, for a total transaction of $67,239.24. Following the completion of the sale, the insider owned 224,056 shares in the company, valued at approximately $1,808,131.92. This trade represents a 3.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Allison C. Hoffman sold 6,176 shares of the firm’s stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $9.06, for a total value of $55,954.56. Following the completion of the sale, the general counsel directly owned 157,309 shares in the company, valued at approximately $1,425,219.54. The trade was a 3.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 50,493 shares of company stock worth $461,983. 5.50% of the stock is owned by company insiders.

Institutional Trading of Phreesia

A number of hedge funds have recently added to or reduced their stakes in PHR. Pale Fire Capital SE acquired a new stake in Phreesia in the 1st quarter worth about $72,481,000. Granahan Investment Management LLC grew its holdings in shares of Phreesia by 73.8% during the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock worth $40,601,000 after purchasing an additional 1,018,987 shares during the period. Prosight Management LP purchased a new stake in shares of Phreesia during the 4th quarter worth about $16,533,000. Millennium Management LLC grew its holdings in shares of Phreesia by 730.7% during the 3rd quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock worth $25,028,000 after purchasing an additional 936,033 shares during the period. Finally, Jacobs Levy Equity Management Inc. purchased a new stake in shares of Phreesia during the 4th quarter worth about $15,213,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Negative Sentiment: Multiple law firms, including Rosen, Bronstein Gewirtz & Grossman, Portnoy, Levi & Korsinsky, Pomerantz, Schall, Faruqi & Faruqi, and The Gross Law Firm, announced or reiterated class-action claims against Phreesia over alleged investor harm during the May 8, 2025 to March 30, 2026 period, which can weigh on sentiment and raise legal overhang. Article Title
• Negative Sentiment: The lawsuits focus on allegations that Phreesia overstated growth durability and made misleading statements about the AccessOne acquisition, reinforcing concerns about execution and disclosure credibility. Article Title
• Neutral Sentiment: Several notices mainly remind investors about the July 13, 2026 lead-plaintiff deadline, which keeps the legal situation in focus but does not add new operational news for the company. Article Title
• Neutral Sentiment: An article also noted that Phreesia is projected to post quarterly earnings, but it did not provide new fundamental results or guidance, so it is unlikely to be the main driver of the stock’s move. Article Title

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.